Figure 2From: Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s product The 90% confidence interval for average bioequivalence measures (Cmax and AUC) plotted over the FDA bioequivalence criteria boundary (The red dotted lines represent the FDA recommended lower and upper limits of the 90% confidence interval for Test/Reference ratio). Back to article page